• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱饵策略:TL1A:DcR3 复合物的结构。

Decoy strategies: the structure of TL1A:DcR3 complex.

机构信息

Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Structure. 2011 Feb 9;19(2):162-71. doi: 10.1016/j.str.2010.12.004.

DOI:10.1016/j.str.2010.12.004
PMID:21300286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3065972/
Abstract

Decoy Receptor 3 (DcR3), a secreted member of the Tumor Necrosis Factor (TNF) receptor superfamily, neutralizes three different TNF ligands: FasL, LIGHT, and TL1A. Each of these ligands engages unique signaling receptors which direct distinct and critical immune responses. We report the crystal structures of the unliganded DcR3 ectodomain and its complex with TL1A, as well as complementary mutagenesis and biochemical studies. These analyses demonstrate that DcR3 interacts with invariant backbone and side-chain atoms in the membrane-proximal half of TL1A which supports recognition of its three distinct TNF ligands. Additional features serve as antideterminants that preclude interaction with other members of the TNF superfamily. This mode of interaction is unique among characterized TNF:TNFR family members and provides a mechanistic basis for the broadened specificity required to support the decoy function of DcR3, as well as for the rational manipulation of specificity and affinity of DcR3 and its ligands.

摘要

诱饵受体 3(DcR3)是肿瘤坏死因子(TNF)受体超家族的一种分泌成员,能中和三种不同的 TNF 配体:FasL、LIGHT 和 TL1A。这些配体中的每一种都与独特的信号受体结合,从而引导不同的关键免疫反应。我们报告了未结合配体的 DcR3 胞外结构域及其与 TL1A 的复合物的晶体结构,以及互补的突变和生化研究。这些分析表明,DcR3 与 TL1A 的膜近端半部分的不变骨架和侧链原子相互作用,从而支持其识别三种不同的 TNF 配体。其他特征则作为反决定因素,阻止与 TNF 超家族的其他成员相互作用。这种相互作用模式在已鉴定的 TNF:TNFR 家族成员中是独特的,为支持 DcR3 的诱饵功能所需的广泛特异性以及 DcR3 及其配体的特异性和亲和力的合理操纵提供了机制基础。

相似文献

1
Decoy strategies: the structure of TL1A:DcR3 complex.诱饵策略:TL1A:DcR3 复合物的结构。
Structure. 2011 Feb 9;19(2):162-71. doi: 10.1016/j.str.2010.12.004.
2
Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3.人 FasL 与其诱饵受体 DcR3 的复合物的晶体结构
Structure. 2016 Nov 1;24(11):2016-2023. doi: 10.1016/j.str.2016.09.009.
3
Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.诱饵受体 3 调控类风湿关节炎滑膜成纤维细胞中多种基因的表达。
Int J Mol Med. 2013 Oct;32(4):910-6. doi: 10.3892/ijmm.2013.1461. Epub 2013 Aug 1.
4
DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.DcR3-TL1A 信号抑制细胞因子诱导的类风湿性滑膜成纤维细胞增殖。
Int J Mol Med. 2011 Sep;28(3):423-7. doi: 10.3892/ijmm.2011.687. Epub 2011 May 2.
5
Mechanistic basis for functional promiscuity in the TNF and TNF receptor superfamilies: structure of the LIGHT:DcR3 assembly.肿瘤坏死因子和肿瘤坏死因子受体超家族中功能混杂的机制基础:LIGHT:DcR3组装体的结构
Structure. 2014 Sep 2;22(9):1252-1262. doi: 10.1016/j.str.2014.06.013. Epub 2014 Jul 31.
6
Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.在银屑病皮损中,肿瘤坏死因子样细胞因子 1A(TL1A)及其受体 DR3 和 DcR3 的上调和核定位。
Exp Dermatol. 2011 Sep;20(9):725-31. doi: 10.1111/j.1600-0625.2011.01304.x. Epub 2011 Jun 14.
7
Biochemical and structural characterization of the human TL1A ectodomain.人TL1A胞外域的生化与结构特征
Biochemistry. 2009 Aug 18;48(32):7636-45. doi: 10.1021/bi900031w.
8
DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.DcR3通过下调E-钙黏蛋白的表达促进肝癌细胞迁移。
Oncol Rep. 2017 Jul;38(1):377-383. doi: 10.3892/or.2017.5685. Epub 2017 May 30.
9
The TL1A/DR3/DcR3 pathway in autoimmune rheumatic diseases.TL1A/DR3/DcR3 通路在自身免疫性风湿病中的作用。
Semin Arthritis Rheum. 2015 Aug;45(1):1-8. doi: 10.1016/j.semarthrit.2015.02.007. Epub 2015 Feb 20.
10
Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritis.类风湿关节炎中肿瘤坏死因子样配体1A和诱饵受体3的血清及滑液水平
Cytokine. 2015 Apr;72(2):185-9. doi: 10.1016/j.cyto.2014.12.026. Epub 2015 Jan 31.

引用本文的文献

1
CD95/Fas stoichiometry in future precision medicine.未来精准医学中的CD95/Fas化学计量学
Cell Death Differ. 2025 Apr 15. doi: 10.1038/s41418-025-01493-9.
2
Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management.推进治疗前沿:用于治疗回肠和肛周克罗恩病的新型药物研发进程
Therap Adv Gastroenterol. 2024 Dec 19;17:17562848241303651. doi: 10.1177/17562848241303651. eCollection 2024.
3
Deciphering the Synthetic and Refolding Strategy of a Cysteine-Rich Domain in the Tumor Necrosis Factor Receptor (TNF-R) for Racemic Crystallography Analysis and d-Peptide Ligand Discovery.解析肿瘤坏死因子受体(TNF-R)中富含半胱氨酸结构域的合成与重折叠策略用于外消旋晶体学分析和d-肽配体发现。
ACS Bio Med Chem Au. 2023 Dec 11;4(1):68-76. doi: 10.1021/acsbiomedchemau.3c00060. eCollection 2024 Feb 21.
4
Computational design of anti-cancer peptides tailored to target specific tumor markers.针对特定肿瘤标志物量身定制的抗癌肽的计算设计。
BMC Chem. 2024 Feb 22;18(1):39. doi: 10.1186/s13065-024-01143-0.
5
Speos: an ensemble graph representation learning framework to predict core gene candidates for complex diseases.Speos:一种用于预测复杂疾病核心基因候选物的集成图表示学习框架。
Nat Commun. 2023 Nov 8;14(1):7206. doi: 10.1038/s41467-023-42975-z.
6
A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation.基于 TRIM21 的生物 PROTAC 凸显了 HuR 降解的治疗益处。
Nat Commun. 2023 Nov 4;14(1):7093. doi: 10.1038/s41467-023-42546-2.
7
Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonists.通过天然配体与合成激动剂来协调激活 TNF 受体的固有特性。
Front Immunol. 2023 Sep 19;14:1236332. doi: 10.3389/fimmu.2023.1236332. eCollection 2023.
8
A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3.一种稳定的、经过工程改造的 TL1A 配体通过与 DR3 的特异性结合来共刺激 T 细胞。
Sci Rep. 2022 Nov 29;12(1):20538. doi: 10.1038/s41598-022-24984-y.
9
Molecular Signature of Neuroinflammation Induced in Cytokine-Stimulated Human Cortical Spheroids.细胞因子刺激的人皮质类器官中诱导的神经炎症的分子特征
Biomedicines. 2022 Apr 29;10(5):1025. doi: 10.3390/biomedicines10051025.
10
A Structural and Functional Perspective of Death Receptor 6.死亡受体6的结构与功能视角
Front Pharmacol. 2022 Mar 24;13:836614. doi: 10.3389/fphar.2022.836614. eCollection 2022.

本文引用的文献

1
Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between IL-13 and IL-13Ralpha2.IL-13 与 IL-13Ralpha2 之间异常高亲和力复合物结构揭示的细胞因子共享识别的分子基础。
Structure. 2010 Mar 10;18(3):332-42. doi: 10.1016/j.str.2010.01.003.
2
Biochemical and structural characterization of the human TL1A ectodomain.人TL1A胞外域的生化与结构特征
Biochemistry. 2009 Aug 18;48(32):7636-45. doi: 10.1021/bi900031w.
3
Sequence, structure, function, immunity: structural genomics of costimulation.序列、结构、功能、免疫:共刺激的结构基因组学
Immunol Rev. 2009 May;229(1):356-86. doi: 10.1111/j.1600-065X.2009.00778.x.
4
Functional characterisation of decoy receptor 3 in Crohn's disease.诱饵受体3在克罗恩病中的功能特性
Gut. 2009 Apr;58(4):483-91. doi: 10.1136/gut.2008.148908. Epub 2008 Nov 27.
5
The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis.死亡受体3-肿瘤坏死因子样蛋白1A通路在炎症性关节炎中引发不良骨病理变化。
J Exp Med. 2008 Oct 27;205(11):2457-64. doi: 10.1084/jem.20072378. Epub 2008 Sep 29.
6
Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease.20号染色体长臂13区和21号染色体长臂22区的基因座与儿童期起病的炎症性肠病相关。
Nat Genet. 2008 Oct;40(10):1211-5. doi: 10.1038/ng.203. Epub 2008 Aug 31.
7
The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases.肿瘤坏死因子家族受体DR3对于多种T细胞介导的炎症性疾病至关重要。
Immunity. 2008 Jul 18;29(1):79-89. doi: 10.1016/j.immuni.2008.04.021. Epub 2008 Jun 19.
8
TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease.TL1A与DR3的相互作用调节辅助性T细胞17(Th17)细胞功能及Th17介导的自身免疫性疾病。
J Exp Med. 2008 May 12;205(5):1049-62. doi: 10.1084/jem.20071364. Epub 2008 Apr 14.
9
Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).诱饵受体3(DcR3)诱导的树突状细胞凋亡
Blood. 2008 Feb 1;111(3):1480-8. doi: 10.1182/blood-2007-09-114850. Epub 2007 Nov 15.
10
X-ray crystal structure of TNF ligand family member TL1A at 2.1A.肿瘤坏死因子配体家族成员TL1A的X射线晶体结构,分辨率为2.1埃。
Biochem Biophys Res Commun. 2007 Dec 7;364(1):1-6. doi: 10.1016/j.bbrc.2007.09.097. Epub 2007 Oct 1.